Health Viewpoints
The U.S. Food and Drug Administration (FDA) on Thursday approved an anthrax vaccine for adults ages 18 to 65, according to Emergent BioSolutions, the vaccine’s maker.
FDA Approves New Anthrax Vaccine for Adults Despite Lack of Publicly Available Information on Testing, Ingredients
Novikov Aleksey/Shutterstock
Brenda Baletti, The Defender
Author
Brenda Baletti Ph.D. is a reporter for The Defender. She wrote and taught about capitalism and politics for 10 years in the writing program at Duke University. She holds a Ph.D. in human geography from the University of North Carolina at Chapel Hill and a master's from the University of Texas at Austin.
